{"title":"Integrating multimodal data for precise subtyping and prognostication in patients with pulmonary mucinous adenocarcinoma.","authors":"Weiwei Yang, Chen Chen, Lue Li, Zehao Chen, Ziyi Chen, Hanbo Le, Yongkui Zhang, Wangyu Zhu","doi":"10.21037/tcr-2026-1241","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pulmonary mucinous adenocarcinoma (PMA) represents a rare lung adenocarcinoma subtype, characterized by a lack of comprehensive pathological classification and prognostic factors. In this study, we propose a multimodal machine learning (ML) framework that integrates multiple data modalities to enhance PMA subtype classification and prognostic prediction.</p><p><strong>Methods: </strong>This retrospective study enrolled 175 primary PMA cases with details of demographic, histopathological, computed tomography (CT) imaging, and epithelial growth factor receptor (<i>EGFR</i>) mutation data. Least absolute shrinkage and selection operator (LASSO) regularized logistic regression model was utilized for histological classification, and Cox proportional hazards model was employed for survival prediction with internal validation.</p><p><strong>Results: </strong>Pure mucinous adenocarcinoma presented a higher prevalence of smaller radiographic or pathological tumor size, lower lobe localization, lower rates of lymph node metastasis and spread through air spaces (STAS), early pathological stage, carcinoembryonic antigen (CEA) ≤5 ng/mL, spiculated margin, Ki-67 low expression and lower frequency of <i>EGFR</i> exon 19 deletion (P=0.002, 0.003, <0.001, <0.001, 0.001, <0.001, 0.002, 0.03, 0.02, 0.001, respectively) compared to mix mucinous and mucin-secreting adenocarcinoma. The ML-derived nomogram achieved discriminative ability, with an area under the curve (AUC) of 0.792 in the training set and 0.687 in the validation set, and exhibited satisfactory calibration for the preoperative diagnosis of pure mucinous adenocarcinoma. Multivariate Cox modeling identified higher CEA levels, and <i>EGFR</i> exon 19 deletion as independent prognostic factors in PMA (P=0.04, 0.049, respectively). Moreover, Kaplan-Meier curves revealed significantly different outcomes between low- and high-risk groups stratified by the nomogram score (P<0.001).</p><p><strong>Conclusions: </strong>Pulmonary pure mucinous adenocarcinoma exhibited lower malignancy compared to the mixed mucinous and mucin-secreting type. The nomogram model developed and validated in this study exhibited promising efficacy in predicting histological subtype preoperatively and survival in patients with PMA, offering guidance for clinicians in diagnosis and prognosis prediction.</p>","PeriodicalId":23216,"journal":{"name":"Translational cancer research","volume":"15 9","pages":"708"},"PeriodicalIF":2.1000,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13657839/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tcr-2026-1241","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/13 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Pulmonary mucinous adenocarcinoma (PMA) represents a rare lung adenocarcinoma subtype, characterized by a lack of comprehensive pathological classification and prognostic factors. In this study, we propose a multimodal machine learning (ML) framework that integrates multiple data modalities to enhance PMA subtype classification and prognostic prediction.
Methods: This retrospective study enrolled 175 primary PMA cases with details of demographic, histopathological, computed tomography (CT) imaging, and epithelial growth factor receptor (EGFR) mutation data. Least absolute shrinkage and selection operator (LASSO) regularized logistic regression model was utilized for histological classification, and Cox proportional hazards model was employed for survival prediction with internal validation.
Results: Pure mucinous adenocarcinoma presented a higher prevalence of smaller radiographic or pathological tumor size, lower lobe localization, lower rates of lymph node metastasis and spread through air spaces (STAS), early pathological stage, carcinoembryonic antigen (CEA) ≤5 ng/mL, spiculated margin, Ki-67 low expression and lower frequency of EGFR exon 19 deletion (P=0.002, 0.003, <0.001, <0.001, 0.001, <0.001, 0.002, 0.03, 0.02, 0.001, respectively) compared to mix mucinous and mucin-secreting adenocarcinoma. The ML-derived nomogram achieved discriminative ability, with an area under the curve (AUC) of 0.792 in the training set and 0.687 in the validation set, and exhibited satisfactory calibration for the preoperative diagnosis of pure mucinous adenocarcinoma. Multivariate Cox modeling identified higher CEA levels, and EGFR exon 19 deletion as independent prognostic factors in PMA (P=0.04, 0.049, respectively). Moreover, Kaplan-Meier curves revealed significantly different outcomes between low- and high-risk groups stratified by the nomogram score (P<0.001).
Conclusions: Pulmonary pure mucinous adenocarcinoma exhibited lower malignancy compared to the mixed mucinous and mucin-secreting type. The nomogram model developed and validated in this study exhibited promising efficacy in predicting histological subtype preoperatively and survival in patients with PMA, offering guidance for clinicians in diagnosis and prognosis prediction.
期刊介绍:
Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients'' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.